PeptideLab.com Sold for $24,995

Domain investor Adam Maysonet shared his latest transaction on the X platform: PeptideLab.com sold for $24,995. The domain previously offered both "Buy Now" and "Negotiate" options, but the buyer ultimately chose a "fixed price," holding the domain for only about three months – a remarkably swift transaction.

From a semantic perspective, PeptideLab.com is a highly specialized and industry-specific premium domain. "Peptide" is a core term in biotechnology, pharmaceuticals, medical aesthetics, and functional health products, encompassing everything from peptide drugs and raw materials to anti-aging treatments and biomaterials research – a high-tech, high-commercial-value keyword. These industries typically involve high technical barriers, rapid market growth, and significant capital investment, thus creating a consistently strong demand for specialized domain names.

The word "Lab" further reinforces the research and development attributes, making the domain semantically clear and well-defined. The combination of "Peptide" and "Lab" is not only natural and smooth, but also allows users to immediately identify the suitable peptide-related research institutions, biopharmaceutical companies, laboratory platforms, or peptide technology service providers.

Sold for less than $25,000, this is a high-value, meaningful, and high-value English two-word .com domain, further demonstrating the stable demand and long-term value of keyword domains in niche technology sectors.